Post by VVMF

🌏 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮: 𝗮 𝗹𝗮𝘂𝗻𝗰𝗵𝗽𝗮𝗱 𝗳𝗼𝗿 𝗴𝗹𝗼𝗯𝗮𝗹 𝗽𝗿𝗼𝗴𝗿𝗮𝗺𝘀 Australia offers a unique capital efficient, low risk pathway to advance CGT programs, supported by generous R&D incentives, global regulatory alignment, and a highly skilled scientific sector.  As a CDMO specialising in viral vector design and manufacturing, VVMF strengthens this advantage by offering end to end capability within an innovation focused and geopolitically stable environment. 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝘄𝗶𝘁𝗵 𝘂𝘀 to accelerate your path to clinic and see why Australia is the strategic choice for next generation therapeutics. Learn more: https://www.vvmf.com.au/ #VVMF #UnlockingtheFutureofMedicine #AustralianAdvantage #AdvancedTherapeutics #CellAndGeneTherapy #CGT #ViralVectors #CDMO #AAV #LentiviralVector #Manufacturing #APACBiotech #AustraliaInnovation Australian Trade and Investment Commission (Austrade) Investment NSW AusBiotech Ann Damien Steven Spezza Hanh Hoang Shaun M. Hayley van der Meer Juliet Woo